119 related articles for article (PubMed ID: 9424132)
21. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
Hübel K; Dale DC; Liles WC
J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
[TBL] [Abstract][Full Text] [Related]
23. [Pentoxifylline in patients with AIDS and oral aphthous ulcers].
Santos J; Márquez M; Rivero A; Salgado F
Med Clin (Barc); 1994 Apr; 102(13):519. PubMed ID: 8208018
[No Abstract] [Full Text] [Related]
24. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
25. Local injections of granulocyte-macrophage colony-stimulating factor (Gm-CSF) for the treatment of radiation-induced mucosa ulcers.
Raoul JL; Cadre B; Le Prisé E; Boucher E
Radiother Oncol; 2003 Sep; 68(3):303-4. PubMed ID: 13129640
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
[TBL] [Abstract][Full Text] [Related]
27. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human granulocyte-macrophage colony-stimulating factor as treatment for chronic leg ulcers.
Borbolla-Escoboza JR; María-Aceves R; López-Hernández MA; Collados-Larumbe MT
Rev Invest Clin; 1997; 49(6):449-51. PubMed ID: 9528304
[TBL] [Abstract][Full Text] [Related]
29. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
[TBL] [Abstract][Full Text] [Related]
30. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
Conran N; Saad ST; Costa FF; Ikuta T
Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286
[TBL] [Abstract][Full Text] [Related]
32. Aphthous ulceration of the gastrointestinal tract in patients with the acquired immunodeficiency syndrome (AIDS).
Bach MC; Howell DA; Valenti AJ; Smith TJ; Winslow DL
Ann Intern Med; 1990 Mar; 112(6):465-7. PubMed ID: 2310108
[No Abstract] [Full Text] [Related]
33. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
Akasheh M; Eastwood D; Vesole DH
Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
[TBL] [Abstract][Full Text] [Related]
34. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.
Almeida R; D'Oliveira A; Machado P; Bacellar O; Ko AI; de Jesus AR; Mobashery N; Brito Santos J; Carvalho EM
J Infect Dis; 1999 Nov; 180(5):1735-7. PubMed ID: 10515844
[TBL] [Abstract][Full Text] [Related]
35. Results of GM-CSF treatment in chemotherapeutic extravasation ulcers.
Vargel I; Canter HI; Erdem A; Altundag MK
J BUON; 2010; 15(3):608-9. PubMed ID: 20941836
[No Abstract] [Full Text] [Related]
36. Giant esophageal aphthous ulcers in AIDS patients: treatment with low-dose corticosteroids.
Sokol-Anderson ML; Prelutsky DJ; Westblom TU
AIDS; 1991 Dec; 5(12):1537-8. PubMed ID: 1814340
[No Abstract] [Full Text] [Related]
37. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
39. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors.
Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S
Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
